166 related articles for article (PubMed ID: 22440733)
21. Biological role of NHERF1 protein expression in breast cancer.
Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A
Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366
[TBL] [Abstract][Full Text] [Related]
22. HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells.
Tan Z; Huang Q; Zang J; Teng SF; Chen TR; Wei HF; Song DW; Liu TL; Yang XH; Fu CG; Hu ZQ; Zhou W; Yan WJ; Xiao JR
Oncotarget; 2017 Apr; 8(16):25885-25896. PubMed ID: 27121066
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
[TBL] [Abstract][Full Text] [Related]
24. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
Malfettone A; Silvestris N; Saponaro C; Ranieri G; Russo A; Caruso S; Popescu O; Simone G; Paradiso A; Mangia A
J Cell Mol Med; 2013 Aug; 17(8):1025-37. PubMed ID: 23991686
[TBL] [Abstract][Full Text] [Related]
25. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma.
Ogane N; Yasuda M; Shimizu M; Miyazawa M; Kamoshida S; Ueda A; Takata K; Sakuma Y; Miyagi Y; Kameda Y
Ann Diagn Pathol; 2010 Feb; 14(1):23-9. PubMed ID: 20123453
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic tumor microenvironment in advanced retinoblastoma.
Sudhakar J; Venkatesan N; Lakshmanan S; Khetan V; Krishnakumar S; Biswas J
Pediatr Blood Cancer; 2013 Oct; 60(10):1598-601. PubMed ID: 23804414
[TBL] [Abstract][Full Text] [Related]
28. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
[TBL] [Abstract][Full Text] [Related]
30. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
Zhou YL; Deng CS
Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
[TBL] [Abstract][Full Text] [Related]
31. Tumoral expression of nuclear cofactor FHL2 is associated with lymphatic metastasis in sporadic but not in HNPCC-associated colorectal cancer.
Al-Nomani L; Friedrichs J; Schüle R; Büttner R; Friedrichs N
Pathol Res Pract; 2015 Feb; 211(2):171-4. PubMed ID: 25554651
[TBL] [Abstract][Full Text] [Related]
32. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
[TBL] [Abstract][Full Text] [Related]
34. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of TrpC5 promotes tumor metastasis via the HIF-1α-Twist signaling pathway in colon cancer.
Chen Z; Zhu Y; Dong Y; Zhang P; Han X; Jin J; Ma X
Clin Sci (Lond); 2017 Oct; 131(19):2439-2450. PubMed ID: 28864720
[TBL] [Abstract][Full Text] [Related]
36. Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis.
Fattahi F; Saeednejad Zanjani L; Vafaei S; Habibi Shams Z; Kiani J; Naseri M; Gheytanchi E; Madjd Z
Diagn Pathol; 2021 Mar; 16(1):26. PubMed ID: 33752711
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1α and semaphorin4D genes involved with tumor-associated macrophage-induced metastatic behavior and clinical significance in colon cancer.
Mu L; Wang J; Chen Y; Li L; Guo X; Zheng S; Jing C
Chin Med J (Engl); 2014; 127(20):3568-75. PubMed ID: 25316231
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma.
Zhu B; Wang Y; Wang X; Wu S; Zhou L; Gong X; Song W; Wang D
Diagn Pathol; 2018 Jul; 13(1):45. PubMed ID: 30021598
[TBL] [Abstract][Full Text] [Related]
40. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
